Abstract
Objectives:
To investigate associations between histology and hepatic mechanical properties measured using multiparametric magnetic resonance elastography (MRE) in adults with known or suspected nonalcoholic fatty liver disease (NAFLD) without histologic fibrosis.
Methods:
This was a retrospective analysis of 88 adults who underwent 3T MR exams including hepatic MRE and MR imaging to estimate proton density fat fraction (MRI-PDFF) within 180 days of liver biopsy. Associations between MRE mechanical properties (mean shear stiffness (|G*|) by 2D and 3D MRE, and storage modulus (G’), loss modulus (G”), wave attenuation (α), and damping ratio (ζ) by 3D MRE) and histology, demographic and anthropometric data were assessed.
Results:
In univariate analyses, patients with lobular inflammation grade ≥ 2 had higher 2D |G*| and 3D G″ than those with grade ≤ 1 (P=0.04). |G*| (both 2D and 3D), G′ and G″ increased with age (rho = 0.25 to 0.31; P ≤ 0.03). In multivariable regression analyses, the association between inflammation grade ≥ 2 remained significant for 2D |G*| (P = 0.01) but not for 3D G″ (P = 0.06); age, sex or BMI did not affect the MRE-inflammation relationship (P > 0.20).
Conclusions:
2D |G*| and 3D G″ were weakly associated with moderate or severe lobular inflammation in patients with known or suspected NAFLD without fibrosis. With further validation and refinement, these properties might become useful biomarkers of inflammation. Age adjustment may help MRE interpretation, at least in patients with early-stage disease.
Keywords: Magnetic resonance imaging, Elasticity imaging techniques, Non-alcoholic fatty liver disease, Inflammation
Introduction
The prevalence of nonalcoholic fatty liver disease (NAFLD) is increasing worldwide [1]. An estimated 25% of patients with NAFLD are thought to have nonalcoholic steatohepatitis (NASH), a more aggressive phenotype [2] that can progress to advanced fibrosis and cirrhosis [3–6] and that is associated with higher rates of morbidity and all-cause mortality [7]. Early detection of NASH would permit early therapeutic intervention that could reduce morbidity and mortality [8].
Currently, reliable assessment of NAFLD/NASH requires liver biopsy and histologic interpretation [9]. NASH is defined as the presence of hepatic steatosis, inflammation and ballooning injury with or without fibrosis [10]. However, biopsy is invasive, prone to sampling variability, observer dependent, impractical for repeated measurements, and inappropriate for population-based studies [11]. For this reason, noninvasive biomarkers for the evaluation of NAFLD are needed [12]. Hepatic proton density fat fraction (PDFF) estimated by confounder-corrected chemical-shift-encoded magnetic resonance imaging (MRI) has been established as a reliable biomarker to quantify hepatic steatosis cross-sectionally and to measure its change longitudinally [13].
MR elastography (MRE) is an advanced technique that estimates liver shear stiffness [14] and other viscoelastic properties [15] based on the analysis of shear wave propagation through the liver. Shear stiffness, also called the magnitude of the complex shear modulus , is the most commonly used MRE parameter; it reflects both elastic and viscous (or damping) elements of tissue stiffness [15; 16] (Table 1). Other MRE parameters – such as storage modulus (G′), loss modulus (G″), wave attenuation (α) and damping ratio (ζ) [15–17] (Table 1) – have been studied more recently. In patients with NASH and other chronic liver diseases, it has been shown that liver fibrosis increases stiffness and related mechanical properties [15; 18; 19]. Fibrosis is just one component of the pathology of NASH, and other factors like lobular inflammation and hepatocellular ballooning play important roles in the progression of disease. However, the ability of MRE to measure these other histological alterations through their impact on mechanical properties remains elusive. Some NAFLD animal models and human studies have suggested that hepatic steatosis, lobular inflammation, and hepatocellular ballooning can affect hepatic mechanical properties [15; 20–23]. One study, for example, reported that the loss modulus (G″) may be sensitive to inflammation, and that G″ and damping ratio (ζ) were elevated in early NASH [15], while other human studies have found no significant associations [24; 25]. A plausible explanation for the inconsistent results in human NAFLD studies is that liver fibrosis may dominate the impact on the hepatic mechanical properties measured using MRE, obscuring potential weaker associations with other histologic features [26]. One way to better understand the association between mechanical properties and histologic features other than liver fibrosis in human NAFLD would be to eliminate the dominant effect of fibrosis by assembling a cohort with histologically-verified absence of fibrosis.
Table 1.
Multiparametric MRE Mechanical Properties (15-17)
| MRE Mechanical Property | Shear Stiffness |G*| (kPa) | Storage Modulus G′ (kPa) | Loss Modulus G″ (kPa) | Wave Attenuation α (m−1) | Damping Ratio ζ |
|---|---|---|---|---|---|
| Definition/formula | Re (G*) | Im (G*) | α = -Im(sqrt(ρω2/G*)) | G″/2 G′ | |
| Physical correlate | Reflects both the elastic and viscous (or damping) elements of stiffness | Elastic element of complex stiffness | Viscous element of complex stiffness | The energy or amplitude loss of the wave as a function of depth and is related to viscosity | Relative contribution of damping or viscous elements to overall tissue stiffness |
MRE magnetic resonance elastography; Re (G*) real part of the complex shear modulus (G*); Im (G*) imaginary part of the complex shear modulus (G*); ρ material density (assumed to be equal to the density of water); ω circular frequency of the vibration.
To this end the purpose of this study was to investigate the association between histology and hepatic mechanical properties measured using MRE in adults with known or suspected NAFLD and with histologically-verified absence of fibrosis. We secondarily sought to assess the inter-relationship and impact of demographic and anthropometric data on mechanical properties.
Materials and Methods
Study design
This was a retrospective, cross-sectional, single-center, secondary analysis of adults who participated in one or more parent NAFLD prospective studies at our institution between October 2010 and January 2017. All subjects in this secondary analysis have been previously reported [27–30]. The prior articles included patients with fibrosis and so differed in their population cohorts. Also, the prior articles either did not report MRE results [27; 29] or reported only a single MRE-measured parameter (shear stiffness) [28; 30]. In this analysis, we examine multiple MRE-measured parameters and we focus on adults with histologically-verified absence of fibrosis.
Inclusion criteria for the parent studies included: age ≥ 18 years; research MR exams performed with acquisition of MRI-PDFF as well as either 2D, or both 2D and 3D MRE; and liver biopsy performed to assess known or suspected NAFLD. Exclusion criteria for the parent studies were excess alcohol consumption; evidence of secondary NAFLD or of other forms of liver disease; contraindication(s) to MR examination; or pregnancy or trying to become pregnant. Two additional exclusion criteria for this secondary analysis were that liver biopsy showed any fibrosis and that the time interval between the MR examinations and biopsy was 180 days or more.
This analysis and the parent studies were approved by our Institutional Review Board and are compliant with the Health Insurance Portability and Accountability Act. All subjects provided written informed consent for the parent studies from which cases were selected for inclusion in this analysis.
MR examinations
Noncontrast MR examinations were performed at 3T (GE Signa EXCITE HDxt, GE Healthcare) and are further described in the Supplementary Material. MRE examinations were performed using a 60-Hz paddle vibration frequency, as previously described [31].
MRE sequences and analysis
Axial breath-hold 2D and 3D MRE images were acquired. In this study, 3D MRE refers to acquisition of the shear wave field in 3 spatial dimensions and with separate motion encoding in the x, y, and z directions, at 3 timepoints in the wave cycle, using a multislice sequence. These vector MRE data are then processed with a full 3D MRE inversion algorithm. Acquisition parameters for MRE are listed in Table 2. Wave images were processed with a 2D multimodel direct-inversion (MMDI) algorithm for 2D MRE, and a 3D direct-inversion algorithm for 3D MRE. Quantitative parametric maps of mechanical properties were generated, including the magnitude of complex shear modulus (|G*|) for both 2D and 3D MRE, as well as the storage modulus (G′), loss modulus (G″), wave attenuation (α), and damping ratio (ζ = G″/2G′) for 3D MRE [15; 32; 33].
Table 2.
Parameters for MR Techniques
| Acquisition Parameters | 2D GRE MRE | 3D SE-EPI MRE | MRI-PDFF |
|---|---|---|---|
| TR (ms) | 50 | 1167 or 1333.8 | ≥ 150 |
| TE (ms) | 20.2 | 51.0 | 1.15, 2.3, 3.45, 4.6, 5.75, 6.9 |
| FA (degrees) | 30 | 90 | 10 |
| Slice thickness (mm) | 10 | 3.5 | 8 |
| Number of slices | 4 | 28-32 | 17-33 |
| Inter-slice gap (mm) | 0 | 0 | 0 |
| Matrix | 256 × 64 | 72 × 72 | 224 x 128 –160 |
| FOV (cm) | 38-48 × 38-48 | 38-48 × 38-48 | 38-44 × 38-44 |
| BW (kHz) | ± 31.25 | ± 250 | ± 142 |
| Number of averages | 1 | 1 | 1 |
| Parallel imaging acceleration factor | 2 | 3 | 1.25 |
2D two-dimensional; 3D three-dimensional; BW Bandwidth; FA Flip angle; FOV Field of view; GRE gradient-recalled echo; MRE magnetic resonance elastography; MRI-PDFF magnetic resonance imaging-proton density fat fraction; SE-EPI spin-echo echo-planar imaging; TR repetition time; TE echo time
MRE images were analyzed offline by two trained image analysts (K.J.G. and J.C., each with ≥ 10 yrs experience) blinded to the clinical and histologic data. (Each MRE exam was analyzed by a different reader.) A free-form region-of-interest (ROI) was drawn on portions of the right hepatic lobe on wave images. The analysis of hepatic MRE properties is further described in the Supplementary Material.
MRI-PDFF sequence and analysis
Hepatic PDFF images were acquired according to previously reported methods [27–30]. Acquisition parameters are listed in Table 2. The analysis of hepatic MRI-PDFF is described further in the Supplementary Material.
Demographic, anthropometric, laboratory and histologic data
Demographic, anthropometric and laboratory data were collected. Histologic scoring was performed by an experienced hepatopathologist (M.A.V., > 10 yrs experience) blinded to the clinical and imaging data. Histologic measures were scored according to the NASH Clinical Research Network histologic scoring system [34]. This scoring system is described further in the Supplementary Material.
Statistical analyses
Statistical analyses were performed by a biostatistical analyst under the supervision of a faculty statistician (T.W. and A.C.G., both with > 20 yrs experience) using statistical computing software (R version 2.15.1; R Foundation for Statistical Computing). Demographic, anthropometric, laboratory, histologic data, and hepatic mechanical properties measured using MRE were summarized descriptively. Continuous variables were expressed as mean ± standard deviation or median with interquartile range, and categorical variables were expressed as number and percentage. A 2-tailed P-value < .05 was considered statistically significant. Correction for multiple comparisons was not applied.
Given that it is a secondary analysis of parent studies, age and sex were compared between patients who were included and those who were excluded in this analysis using a t-test and a chi-squared test of proportions, respectively. Steatosis grade and NAFLD activity score (NAS) were treated as ordinal. All other histologic variables were dichotomized and are further described in the Supplementary Material.
In univariate analyses, the relationship between MRE mechanical properties and dichotomized histologic variables were assessed using Wilcoxon-Mann-Whitney tests. Additionally, Spearman’s correlation coefficients (rho) were calculated to explore the association between MRE mechanical properties and continuous (age, body mass index (BMI), MRI-PDFF) or ordinal (histology-determined steatosis, NAS) variables. Relationships that showed significant differences in univariate analyses were then further examined using multivariable logistic regression analyses. In each regression, the predictors consisted of one MRE property as well as the covariates of age (continuous), sex and BMI (continuous).
Results
Cohort characteristics
Of 203 participants in the parent studies, 88 adults (mean age, 48.7 years; range, 18.5 to 75.8 years) were selected for this analysis. 114 participants were excluded because they had biopsy-proven liver fibrosis. One participant was excluded because the MR-biopsy interval exceeded 180 days. Included and excluded patients did not differ on age (p = 0.57) or sex (p = 0.87).
All 88 included subjects had undergone 2D MRE, and 77/88 (87.5%) also had undergone 3D MRE in the parent studies. The majority (79/88 for 2D MRE, 72/77 for 3D MRE) had biopsy-proven NAFLD; 57/88 for 2D MRE and 49/77 for 3D MRE had grade 2 or 3 lobular inflammation, while all other included patients had grade 1 or no lobular inflammation. The mean and median time interval between MR imaging and biopsy was 33 and 19 days (range, 1 to 173 days), respectively. The mean shear stiffness (|G*|) from 2D and 3D MRE were 2.38 kPa and 2.04 kPa, respectively. The mean storage modulus (G′) and loss modulus (G″) from 3D MRE were 1.98 kPa and 0.38 kPa, respectively. Demographics, anthropometry, laboratory, histology, and cohort 2D and 3D MRE mechanical properties are summarized in Table 3.
Table 3.
Demographics, Anthropometry, Laboratory, Histology and Cohort 2D and 3D MRE Mechanical Properties of Study Cohort
| Characteristic | Values |
|---|---|
| Demographic and anthropometric data (n=88) | |
| Age at biopsy, y, mean ± SD | 48.7 ± 14.3 |
| Female, n (%) | 52 (59.1) |
| Male, n (%) | 36 (40.9) |
| BMI, kg/m2, mean ± SD | 31.4 ± 5.3 |
| Laboratory data (n=88) | |
| AST, U/L, median (IQR) | 28.0 (10) |
| ALT, U/L, median (IQR) | 42.0 (32) |
| Platelet count, 109/L, median (IQR) | 248,500 (95,500) |
| Histologic data (n=88) | |
| Steatosis, n (%) | |
| 0 | 10 (11.4) |
| 1 | 31 (35.2) |
| 2 | 32 (36.4) |
| 3 | 15 (17.0) |
| Lobular inflammation, n (%) | |
| 0 | 10 (11.4) |
| 1 | 47 (53.4) |
| 2 | 30 (34.1) |
| 3 | 1 (1.1) |
| Ballooning, n (%) | |
| 0 | 50 (56.8) |
| 1 | 34 (38.6) |
| 2 | 4 (4.6) |
| Diagnosis of NASH, n (%) | |
| 0 No NAFLD | 9 (10.2) |
| 1 NAFLD, not NASH | 35 (39.8) |
| 2 Borderline NASH | 13 (14.8) |
| 3 Definite NASH | 31 (35.2) |
| NAS, mean ± SD | 3.3 ± 1.7 |
| 2D MRE (n=88) | |
| Shear stiffness |G*|, kPa, mean ± SD | 2.38 ± 0.45 |
| 3D MRE (n=77) | |
| Shear stiffness |G*|, kPa, mean ± SD | 2.04 ± 0.36 |
| Storage modulus G’, kPa, mean ± SD | 1.98 ± 0.35 |
| Loss modulus G”, kPa, mean ± SD | 0.38 ± 0.12 |
| Wave attenuation α, m−1, mean ± SD | 28.5 ± 6 |
| Damping ratio ζ, mean ± SD | 0.1 ± 0.03 |
| Interval between MR and biopsy, day, mean ± SD (median; range) (n=88) | 33 ± 37 (19; 1-173) |
ALT alanine aminotransferase; AST aspartate aminotransferase; BMI body mass index; IQR interquartile range; MRE magnetic resonance elastography; NAFLD nonalcoholic fatty liver disease; NAS NAFLD activity score; NASH nonalcoholic steatohepatitis; SD standard deviation.
Univariate associations between histologic measures and MRE mechanical properties
Mean hepatic shear stiffness (|G*|) measured using 2D MRE and loss modulus (G″) measured using 3D MRE were significantly higher for participants with lobular inflammation grade ≥ 2 vs. ≤ 1 (2.58 ± 0.61 vs. 2.27 ± 0.29 kPa, P = 0.04 and 0.42 ± 0.12 vs. 0.36 ± 0.11 kPa, P = 0.04, respectively) (Figures 1, 2). For participants with lobular inflammation grade ≥ 2 vs. ≤ 1, the difference in hepatic shear stiffness (|G*|) or storage modulus (G′) measured by 3D MRE did not reach statistical significance (P = 0.08 and 0.09, 2.16 ± 0.46 vs. 1.97 ± 0.26 kPa and 2.10 ± 0.46 vs. 1.91 ± 0.25 kPa, respectively) (Figure 2). Hepatic wave attenuation (α) and damping ratio (ζ) showed no differences between lobular inflammation grade ≥ 2 and grade ≤ 1 (P = 0.84 and 0.31, respectively) (Figure 2).
Figure 1.

Boxplots show that in patients without liver fibrosis, the presence of inflammation is associated with significantly higher shear stiffness |G*| measured using 2D MR elastography (MRE) (A) and loss modulus G″ measured using 3D MRE (B). Scatterplots show that MRE-derived biomarkers including shear stiffness |G*| (both 2D and 3D) (C)-(D), storage modulus G′ (E) and loss modulus G″ (F) tended to increase with age. The ellipses in the plots, computed based on the variance and covariance of the X and Y measures being plotted, are visual representations of the strength and direction of the relationship between the X and Y.
Figure 2.

Examples of 2D (A) and 3D (B) MRE images in a 52-year-old woman with no lobular inflammation, and in a 57-year-old woman with lobular inflammation grade 2. The white line depicts the manually traced region of interest (ROI). It should be noted that the ROIs on the shear stiffness (|G*|), storage modulus (G′) and loss modulus (G″) maps are copies of the ROI drawn using the magnitude and wave information for display purposes, but the values of |G*|, G′, G″ and wave attenuation (α) were derived from ROI-based mean complex shear modulus values mathematically.
No MRE mechanical property showed any significant association with steatosis, hepatocellular ballooning, NAS, or diagnosis of NASH (P > 0.10). Results of univariate associations between MRE histologic measures and mechanical properties are summarized in Table 4.
Table 4.
Results of Associations between MRE Mechanical Properties and Histologic Features, Age, BMI and MRI-PDFF using Wilcoxon Mann-Whitney or Spearman’s Correlation Tests
| Characteristics | Scores | 2D MRE |
3D MRE |
||||
|---|---|---|---|---|---|---|---|
| Shear Stiffness |G*| (kPa) |
Shear Stiffness |G*| (kPa) |
Storage Modulus G′ (kPa) |
Loss Modulus G″ (kPa) |
Wave Attenuation α (m−1) |
Damping Ratio ζ (G″/2G’) |
||
|
|
|
||||||
| Steatosis | Grade 0-3 | Rho = 0.11, P = 0.32 |
Rho = −0.16, P = 0.17 |
Rho = −0.17, P = 0.15 |
Rho = 0.05, P = 0.70 |
Rho = 0.18, P = 0.12 |
Rho = 0.09, P = 0.41 |
| Lobular Inflammation | Grade ≥ 2 vs. ≤ 1 |
2.58 ± 0.61 vs. 2.27 ± 0.29,
P = 0.04* |
2.16 ± 0.46 vs. 1.97 ± 0.26, P = 0.08 |
2.10±0.46 vs. 1.91 ± 0.25, P = 0.09 |
0.42 ± 0.12 vs. 0.36 ± 0.11,
P = 0.04* |
28.50± 6.42 vs. 28.48 ± 6.56, P = 0.84 |
0.10 ± 0.02 vs. 0.10 ± 0.03, P = 0.31 |
| Hepatocellular Ballooning | Grade ≥ 1 vs. 0 | 2.39 ± 0.46 vs. 2.37 ± 0.45, P = 0.92 |
2.04 ± 0.41 vs. 2.03 ± 0.31, P = 0.80 |
1.99 ± 0.40 vs. 1.97 ± 0.31, P = 0.86 |
0.39 ± 0.11 vs. 0.38 ± 0.13, P = 0.91 |
28.39± 6.37 vs. 28.56 ± 6.61, P = 0.94 |
0.10 ± 0.02 vs. 0.10 ± 0.03, P = 0.82 |
| NAS | Score 0-8 | Rho = 0.15, P = 0.18 |
Rho = −0.04, P = 0.73 |
Rho = −0.04, P = 0.73 |
Rho = 0.12, P = 0.29 |
Rho = 0.12, P = 0.29 |
Rho = 0.12, P = 0.31 |
| Diagnosis of NASH | Definite/borderline NASH vs. no NASH (Grade ≥ 2 vs. ≤ 1) | 2.44 ± 0.49 vs. 2.33 ± 0.41, P = 0.46 |
2.08 ± 0.42 vs. 1.99 ± 0.27, P = 0.61 |
2.02 ± 0.41 vs. 1.94 ± 0.27, P = 0.62 |
0.41 ± 0.12 vs. 0.36 ± 0.12, P = 0.11 |
28.84± 6.36 vs. 28.13 ± 6.64, P = 0.50 |
0.10 ± 0.03 vs. 0.09 ± 0.03, P = 0.17 |
| Definite NASH vs. not definite NASH (Grade 3 vs. ≤ 2) | 2.50 ± 0.55 vs. 2.32 ± 0.38, P = 0.17 |
2.10 ± 0.47 vs. 2.00 ± 0.26, P = 0.76 |
2.04 ± 0.46 vs. 1.94 ± 0.25, P = 0.76 |
0.41 ± 0.11 vs. 0.37 ± 0.12, P = 0.22 |
28.60± 6.92 vs. 28.42 ± 6.25, P = 1.00 |
0.10 ± 0.02 vs. 0.10 ± 0.03, P = 0.39 |
|
| Age | Continuous |
Rho = 0.27,
P = 0.01* |
Rho = 0.31,
P = 0.01* |
Rho = 0.30,
P = 0.01* |
Rho = 0.25,
P = 0.03* |
Rho = −0.03, P = 0.78 |
Rho = 0.09, P = 0.44 |
| BMI | Continuous | Rho = 0.06, P = 0.58 |
Rho = 0.01, P = 0.91 |
Rho = 0.01, P = 0.90 |
Rho = −0.08, P = 0.48 |
Rho = −0.15, P = 0.20 |
Rho = −0.06, P = 0.58 |
| MRI-PDFF | Continuous | Rho = 0.08, P = 0.44 |
Rho = −0.19, P = 0.10 |
Rho = −0.19, P = 0.10 |
Rho = −0.05, P = 0.68 |
Rho = 0.10, P = 0.38 |
Rho = 0.01, P = 0.95 |
The results were significant at a significance level of 0.05. Significant results are in bold. BMI body mass index; MRE magnetic resonance elastography; MRI-PDFF magnetic resonance imaging-proton density fat fraction; NAS NAFLD activity score; NASH nonalcoholic steatohepatitis.
Univariate associations between MRE mechanical properties and age, BMI, MRI-PDFF
Hepatic shear stiffness (|G*|) (both 2D and 3D), storage modulus (G′) and loss modulus (G′) increased significantly with age; the Spearman’s coefficients ranged from 0.25 to 0.31 (all P ≤ 0.03) (Table 4; Figure 1). There was no significant association between any MRE mechanical property and BMI or MRI-PDFF (rho = −0.15 to 0.06, all P ≥ 0.20 for BMI; rho = −0.19 to 0.10, all P ≥ 0.10 for MRI-PDFF) (Table 4).
Multivariable regression analysis
After adjusting for age, sex, and BMI in multivariable regression analysis, the association between grade ≥ 2 inflammation remained significant for |G*| measured using 2D MRE (P = 0.01) but not for G″ measured using 3D MRE (P = 0.06); age, sex or BMI did not affect the MRE-inflammation relationship (P > 0.20). Results of multivariable analyses are summarized in Table 5.
Table 5.
Odds Ratios and P-values from the Multivariable Regression Analysis with Lobular Inflammation Grade ≥ 2 vs. ≤ 1 as Outcome
| Model | Predictors | Odds Ratio | P |
|---|---|---|---|
| 1 | Shear Stiffness (|G*|) by 2D MRE | 6.29 | 0.01 * |
| Age | 1.00 | 0.88 | |
| Sex | 1.24 | 0.67 | |
| BMI | 0.97 | 0.46 | |
| 2 | Shear Stiffness (|G*|) by 3D MRE | 4.58 | 0.06 |
| Age | 1.01 | 0.62 | |
| Sex | 1.01 | 0.98 | |
| BMI | 0.97 | 0.58 | |
| 3 | Storage Modulus (G′) by 3D MRE | 4.50 | 0.07 |
| Age | 1.01 | 0.59 | |
| Sex | 1.02 | 0.98 | |
| BMI | 0.97 | 0.58 | |
| 4 | Loss Modulus (G′) by 3D MRE | 72.47 | 0.06 |
| Age | 1.01 | 0.52 | |
| Sex | 1.20 | 0.72 | |
| BMI | 0.98 | 0.65 | |
| 5 | Wave Attenuation (α) by 3D MRE | 1.01 | 0.89 |
| Age | 1.02 | 0.22 | |
| Sex | 1.28 | 0.62 | |
| BMI | 0.98 | 0.71 | |
| 6 | Damping Ratio (ζ) by 3D MRE | 8407.67 | 0.31 |
| Age | 1.02 | 0.24 | |
| Sex | 1.33 | 0.57 | |
| BMI | 0.98 | 0.72 |
The results were significant at a significance level of 0.05. Significant results are in bold. BMI body mass index; MRE magnetic resonance elastography
Discussion
In this study, we performed a secondary analysis of prospectively acquired data in adults with known or suspected NAFLD without histologic fibrosis to determine the possible association of pathological features with MRE-determined tissue mechanical properties. Hepatic inflammation is one of the responses to injury and considered an important pathogenic component of NAFLD/NASH. When the liver is injured, lymphocytes and macrophages in the parenchyma release chemokines, which attract and promote retention of additional immune cells in the tissue; the infiltration into the liver of immune cells and the release of adhesion factors are thought to increase the viscosity of liver tissue [17]. We therefore postulated that inflammation might impact MRE measurements. We found that there were relationships between elevated mean hepatic shear stiffness (measured using 2D MRE) and elevated mean hepatic loss modulus (measured using 3D MRE) with moderate to severe lobular inflammation, and the relationship with elevated mean hepatic shear stiffness (measured using 2D MRE) remained significant after adjusting for age, sex, and BMI. These findings suggest that with further refinement, MRE-based assessments of hepatic mechanical properties may permit detection of early alterations of histopathology prior to the development of fibrosis. Further studies are needed to verify our results.
Other authors have attempted to explore the relationship of inflammation and MRE measures. Chen et al. [21] found that hepatic stiffness measured using 2D MRE correlated with inflammation grade in NAFLD patients. Although the authors did not exclude patients with fibrosis, they adjusted for the effects of fibrosis in a multivariable analysis. Similarly, Shi et al. [35] found that hepatic stiffness measured using 2D MRE was significantly higher in patients with moderate or severe inflammation compared with no or mild inflammation in HBV patients without fibrosis. Others have not demonstrated this same correlation. Leitão et al. [25] found that in patients with mixed chronic liver disease, inflammation was not independently associated with hepatic viscoelastic properties measured using MRE, possibly because patients in their study had various etiologies, and patients with fibrosis were not excluded. While not the first to attempt to measure inflammation using MRE, our study has some advantages: 1) we attempted to isolate the possible effect of inflammation by focusing on patients with early stage NAFLD and excluding patients with more advanced disease (i.e. those with fibrosis) and 2) we performed all MRE examinations under controlled protocols as all participants were enrolled in parent research studies.
Our finding that the mean loss modulus measured using 3D MRE is significantly higher in subjects with moderate to severe lobular inflammation compared to subjects with no or mild lobular inflammation in univariate analyses provides a possible positive signal for future research. After adjusting for other covariates, loss modulus measured using 3D MRE almost reached significance with a p-values of 0.06. This suggests that studies with larger sample sizes might find a statistically significant contribution, help to verify the incremental benefit of 3D MRE in assessing inflammation, and support the eventual clinical adoption of 3D MRE, which currently is used mainly in the research domain. Moreover, although 3D MRE and 2D MRE ended up with p-values on different sides of the significance threshold of 0.05 in a multivariable model, they were both close to that threshold, and it is possible that the two methods provide complementary information. Future studies are warranted.
The storage modulus reflects the elasticity of tissue and is thought to be sensitive mainly to fibrosis [15]. Thus, the small, nonsignificant (P = 0.09) difference in storage modulus between patients with lobular inflammation grade ≥ 2 vs. ≤ 1 is not surprising, given that our analysis included only subjects with no fibrosis.
As our secondary aim, we evaluated the relationship of age, MRI-PDFF and BMI with MRE measurements. We found that mean hepatic shear stiffness, and storage and loss moduli increased with age (all P ≤ 0.03). A prior individual participant data pooled analysis reported similar observations in NAFLD patients with no or varying stages of fibrosis [36], finding a modest positive correlation between age and liver stiffness measured using MRE. To the best of our knowledge, our findings are the first report of associations between age and hepatic mechanical properties measured using multiparametric MRE in NAFLD patients without fibrosis. Our findings suggest that age adjustment may help interpret MRE results, at least in patients with early-stage disease.
Prior studies have reported no association between MRI-determined hepatic signal fat fraction [21] or PDFF [37] and 2D MRE-determined shear stiffness in NAFLD patients, the majority of whom had fibrosis. Our study helps to verify these findings in a NAFLD cohort without fibrosis, and we also add to those findings by showing that other MRE-assessed mechanical properties were not associated with hepatic histologic steatosis or MRI-PDFF (all P ≥ 0.10). No hepatic MRE mechanical property had a significant association with BMI, hepatocellular ballooning grade, NAS, or diagnosis of NASH score (all P > 0.10).
Our study has several limitations. First, this is a retrospective, single-center and cross-sectional study, and reproducibility of multiparametric MRE was not evaluated. We do provide potential positive signal to explore in future prospective work that may aim to establish the repeatability/reproducibility of and refine and validate these MRE parameters as biomarkers of inflammation. Second, given the continuous spectrum of histological alterations of NAFLD, our sample size is relatively small. Histologic data were not uniformly distributed across grades/stages; we had more cases with mild or moderate inflammation than cases without NAFLD or severe inflammation, which prevented a comprehensive analysis of MRE mechanical properties grading inflammation across its entire biological range. A larger study population with sufficient subjects in each grade/stage is required to more completely assess the association between histologic features and MRE parameters in the future. Third, all of the MRE mechanical parameters reported in this study are frequency-dependent properties [15; 19]. MRE data in our study were acquired at only one frequency (60 Hz). Yin et al. [38] found that loss modulus measured using 3D MRE at 80 Hz had significant positive effects in predicting lobular inflammation in a NAFLD mouse model. Future studies are necessary to determine the frequency or frequencies with the best multiparametric MRE diagnostic performance for the assessment of histologic measures of NAFLD, as well as the possible role of measuring frequency dispersion (how the parameters change with frequency) [39; 40]. Finally, the interval between the MR examinations and biopsy within 180 days is relatively large although acceptable [23; 41]. Moreover, the mean MR-biopsy interval was only 33 days, reducing the risk of interim biological change.
In conclusion, moderate to severe inflammation was associated with elevated mean hepatic shear stiffness (measured using 2D MRE) and elevated mean hepatic loss modulus (measured using 3D MRE) in patients with known or suspected NAFLD, but with histology-confirmed absence of liver fibrosis, and the relationship of 2D MRE-stiffness with inflammation grade remained significant after adjusting for age, sex, and BMI. Our results suggest that with further technical refinement these MRE-assessed mechanical properties may permit detection of inflammation before the onset of fibrosis in NAFLD. In addition, increasing age was found to be associated with higher mean hepatic shear stiffness, and storage and loss moduli, suggesting that age adjustment may help interpret MRE results, at least in patients with early-stage disease.
Supplementary Material
Key points:
Moderate to severe lobular inflammation was associated with hepatic elevated shear stiffness and elevated loss modulus (P=0.04) in patients with known or suspected NAFLD without liver fibrosis; this suggests that with further technical refinement these MRE-assessed mechanical properties may permit detection of inflammation before the onset of fibrosis in NAFLD.
Increasing age is associated with higher hepatic shear stiffness, and storage and loss moduli (rho = 0.25 to 0.31; P ≤ 0.03). this suggests that age adjustment may help interpret MRE results, at least in patients with early-stage NAFLD.
Acknowledgement
The authors wish to thank GE Healthcare who provides research support to the University of California, San Diego, CA and the University of Wisconsin, Madison, WI. This work has been supported by the following grants:
1. National Institutes of Health (NIH) Grants: K23DK090303, R01DK083380, R01DK088925, R01DK100651, K24DK102595, R01DK106419, EB001981, EB017197
2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant: U01DK061718
3. Mayo Clinic Center for Individualized Medicine Imaging Biomarker Discovery Program.
Abbreviations
- BMI
body mass index
- MMDI
multimodel direct inversion
- MRE
magnetic resonance elastography
- MRI
magnetic resonance imaging
- NAFLD
nonalcoholic fatty liver disease
- NAS
nonalcoholic fatty liver disease activity score
- NASH
nonalcoholic steatohepatitis
- PDFF
proton density fat fraction
- ROI
region of interest
References
- 1.Loomba R, Sanyal AJ (2013) The global NAFLD epidemic. Nat Rev Gastroenterol Hepatol 10:686–690 [DOI] [PubMed] [Google Scholar]
- 2.Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M (2016) Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 64:73–84 [DOI] [PubMed] [Google Scholar]
- 3.Evans CD, Oien KA, MacSween RN, Mills PR (2002) Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury? J Clin Pathol 55:689–692 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C (2004) Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 40:820–826 [DOI] [PubMed] [Google Scholar]
- 5.Harrison SA, Torgerson S, Hayashi PH (2003) The natural history of nonalcoholic fatty liver disease: a clinical histopathological study. American Journal of Gastroenterology 98:2042–2047 [DOI] [PubMed] [Google Scholar]
- 6.Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413–1419 [DOI] [PubMed] [Google Scholar]
- 7.Alkhouri N, McCullough AJ (2012) Noninvasive diagnosis of NASH and liver fibrosis within the spectrum of NAFLD. Gastroenterol Hepatol (N Y) 8:661–668 [PMC free article] [PubMed] [Google Scholar]
- 8.Gaidos JK, Hillner BE, Sanyal AJ (2008) A decision analysis study of the value of a liver biopsy in nonalcoholic steatohepatitis. Liver Int 28:650–658 [DOI] [PubMed] [Google Scholar]
- 9.Stinton LM, Loomba R (2014) Recommendations for liver biopsy evaluation in non-alcoholic fatty liver disease. Minerva Gastroenterologica e Dietologica 60:5–13 [PubMed] [Google Scholar]
- 10.Puri P, Sanyal AJ (2012) Nonalcoholic fatty liver disease: Definitions, risk factors, and workup. Clinical Liver Disease 1:99–103 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11.Bedogni G, Nobili V, Tiribelli C (2014) Epidemiology of fatty liver: an update. World Journal of Gastroenterology 20:9050–9054 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Noureddin M, Loomba R (2012) Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers. Clinical Liver Disease 1:104–107 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Reeder SB, Hu HH, Sirlin CB (2012) Proton density fat-fraction: a standardized MR-based biomarker of tissue fat concentration. Journal of Magnetic Resonance Imaging 36:1011–1014 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Tang A, Cloutier G, Szeverenyi NM, Sirlin CB (2015) Ultrasound elastography and MR elastography for assessing liver fibrosis: Part 1, principles and techniques. Am J Roentgenol 205:22–32 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Yin M, Glaser KJ, Manduca A et al. (2017) Distinguishing between hepatic inflammation and fibrosis with MR elastography. Radiology 284:694–705 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Meyers MA, Chawla KK (2008) Elasticity and ViscoelasticityIn: Mechanical Behavior of Materials, 2nd edn. Cambridge University Press, New York [Google Scholar]
- 17.Sinkus R, Lambert S, Abd-Elmoniem KZ et al. (2018) Rheological determinants for simultaneous staging of hepatic fibrosis and inflammation in patients with chronic liver disease. NMR Biomed 31:e3956. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Singh S, Venkatesh SK, Wang Z et al. (2015) Diagnostic performance of magnetic resonance elastography in staging liver fibrosis: a systematic review and meta-analysis of individual participant data. Clin Gastroenterol Hepatol 13:440–451.e6 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Asbach P, Klatt D, Schlosser B et al. (2010) Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology 257:80–86 [DOI] [PubMed] [Google Scholar]
- 20.Allen AM, Yin M, Venkatesh SK et al. (2017) Novel multiparametric magnetic resonance elastography (MRE) protocol accurately predicts NAS score for NASH diagnosis. Journal of Hepatology 66:S659–S660 [Google Scholar]
- 21.Chen J, Talwalkar JA, Yin M, Glaser KJ, Sanderson SO, Ehman RL (2011) Early detection of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease by using MR elastography. Radiology 259:749–756 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Trout AT, Sheridan RM, Serai SD et al. (2018) Diagnostic performance of MR elastography for liver fibrosis in children and young adults with a spectrum of liver diseases. Radiology 287:824–832 [DOI] [PubMed] [Google Scholar]
- 23.Yin M, Glaser KJ, Talwalkar JA, Chen J, Manduca A, Ehman RL (2016) Hepatic MR elastography: clinical performance in a series of 1377 consecutive examinations. Radiology 278:114–124 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Yin M, Talwalkar JA, Glaser KJ et al. (2007) Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 5:1207–1213.e2 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Leitão HS, Doblas S, Garteiser P et al. (2017) Hepatic fibrosis, inflammation, and steatosis: influence on the MR viscoelastic and diffusion parameters in patients with chronic liver disease. Radiology 283:98–107 [DOI] [PubMed] [Google Scholar]
- 26.Hirsch S, Sack I, Braun J (2017) MRE of Abdomen, Pelvis, and Intervertebral Disc. In: Magnetic resonance elastography: physical background and medical applications. 1st edn. John Wiley&Sons, Weinheim, Germany, pp 283–311 [Google Scholar]
- 27.Luo RB, Suzuki T, Hooker JC et al. (2018) How bariatric surgery affects liver volume and fat density in NAFLD patients. Surg Endosc 32:1675–1682 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Loomba R, Sirlin CB, Ang B et al. (2015) Ezetimibe for the treatment of nonalcoholic steatohepatitis: assessment by novel magnetic resonance imaging and magnetic resonance elastography in a randomized trial (MOZART trial). Hepatology 61:1239–1250 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Middleton MS, Heba ER, Hooker CA et al. (2017) Agreement between magnetic resonance imaging proton density fat fraction measurements and pathologist-assigned steatosis grades of liver biopsies from adults with nonalcoholic steatohepatitis. Gastroenterology 153:753–761 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Caussy C, Chen J, Alquiraish MH et al. (2018) Association between obesity and discordance in fibrosis stage determination by magnetic resonance vs transient elastography in patients with nonalcoholic liver disease. Clin Gastroenterol Hepatol 16:1974–1982.e7 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Wang K, Manning P, Szeverenyi N et al. (2017) Repeatability and reproducibility of 2D and 3D hepatic MR elastography with rigid and flexible drivers at end-expiration and end-inspiration in healthy volunteers. Abdom Radiol (NY) 42:2843–2854 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Allen AM, Shah VH, Therneau TM et al. (2019) Multiparametric Magnetic Resonance Elastography Improves the Detection of NASH Regression Following Bariatric Surgery. Hepatology communications 4:185–192 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Hiscox LV, Schwarb H, McGarry MDJ, Johnson CL (2021) Aging Brain Mechanics: Progress and Promise of Magnetic Resonance Elastography. Neuroimage. DOI: 10.1016/j.neuroimage.2021.117889 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Kleiner DE, Brunt EM, Van Natta M et al. (2005) Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41:1313–1321 [DOI] [PubMed] [Google Scholar]
- 35.Shi Y, Guo Q, Xia F et al. (2014) MR elastography for the assessment of hepatic fibrosis in patients with chronic hepatitis B infection: does histologic necroinflammation influence the measurement of hepatic stiffness? Radiology 273:88–98 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Singh S, Venkatesh SK, Loomba R et al. (2016) Magnetic resonance elastography for staging liver fibrosis in non-alcoholic fatty liver disease: a diagnostic accuracy systematic review and individual participant data pooled analysis. Eur Radiol 26:1431–1440 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Loomba R, Wolfson T, Ang B et al. (2014) Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: a prospective study. Hepatology 60:1920–1928 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Yin Z, Murphy MC, Li J et al. (2019) Prediction of nonalcoholic fatty liver disease (NAFLD) activity score (NAS) with multiparametric hepatic magnetic resonance imaging and elastography. Eur Radiol 29:5823–5831 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Asbach P, Klatt D, Hamhaber U et al. (2008) Assessment of liver viscoelasticity using multifrequency MR elastography. Magn Reson Med 60:373–379 [DOI] [PubMed] [Google Scholar]
- 40.Garteiser P, Doblas S, Van Beers BE (2018) Magnetic resonance elastography of liver and spleen: Methods and applications. NMR in Biomedicine 31:e3891. [DOI] [PubMed] [Google Scholar]
- 41.Park CC, Nguyen P, Hernandez C et al. (2017) Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease. Gastroenterology 152:598–607.e2 [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
